Policy & Research

Share

Testimony: A Health Impact Assessment on Legalization of Medical Marijuana in Kansas (HB 2049)

By Tatiana Y. Lin, M.A. | January 22, 2016

Testimony: A Health Impact Assessment on Legalization of Medical Marijuana in Kansas (HB 2049)
Photo by Jennifer Tinajero Tatiana Lin, KHI senior analyst and strategy team leader, presenting neutral testimony at the Senate Committee on Corrections and Juvenile Justice.

On January 21, 2016, KHI's Tatiana Lin, senior analyst and strategy team leader, presented neutral testimony to the Senate Committee on Corrections and Juvenile Justice for House Bill 2049. This bill, also know as “Otis’s Law," aims to legalize cannabis oil for seizure-related conditions such as epilepsy. During the testimony, KHI provided a summary of similar “restrictive laws” passed by 17 states as of December 2015. In addition, findings and recommedations were shared with the committee from KHI's recent completion of a health impact assessment (HIA) on the legalization of medical marijuana in Kansas.

The Kansas Health Institute delivers credible information and research enabling policy leaders to make informed health policy decisions that enhance their effectiveness as champions for a healthier Kansas. The Kansas Health Institute is a nonprofit, nonpartisan health policy and research organization based in Topeka, established in 1995 with a multiyear grant from the Kansas Health Foundation.